Cipher Pharmaceuticals Inc.
CPHRF
Price:
$10.25
Market Cap:
$261.95M
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream that reduces the growth of unwanted facial hair in women; BRINAVESS, a treatment for sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet drug. The company's licensed products comprise CIP-Isotretinoin; Lipofen (CIP-Fenofibrate), a formul...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2006-02-02
Stock Exchange
PNK
Ticker
CPHRF
PE Ratio
[16.27]
ROE
[17.93%]
Current Ratio
[2.00]
Dividend Yield
[0%]
Enterprise Value
[293.17M]
Dividend History
The ROE as of December 2024 (TTM) for Cipher Pharmaceuticals Inc. (CPHRF) is 17.93%
According to Cipher Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current ROE is 17.93%. This represents a change of 279.08% compared to the average of 4.73% of the last 4 quarters.
Cipher Pharmaceuticals Inc. (CPHRF) Historical ROE (quarterly & annually)
How has CPHRF ROE performed in the past?
The mean historical ROE of Cipher Pharmaceuticals Inc. over the last ten years is -15.32%. The current 17.93% ROE has changed -216.99% with respect to the historical average. Over the past ten years (40 quarters), CPHRF's ROE was at its highest in in the December 2022 quarter at 30.71%. The ROE was at its lowest in in the September 2016 quarter at -74.13%.
Average
-15.32%
Median
12.76%
Minimum
-217.33%
Maximum
41.57%
Cipher Pharmaceuticals Inc. (CPHRF) ROE by Quarter and Year
Discovering the peaks and valleys of Cipher Pharmaceuticals Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 427.74%
Maximum Annual ROE = 41.57%
Minimum Annual Increase = -6765.59%
Minimum Annual ROE = -217.33%
| Year | ROE | Change |
|---|---|---|
| 2023 | 25.31% | -39.10% |
| 2022 | 41.57% | 108.41% |
| 2021 | 19.94% | 43.12% |
| 2020 | 13.94% | 20.41% |
| 2019 | 11.57% | 427.74% |
| 2018 | 2.19% | -88.58% |
| 2017 | 19.20% | -108.83% |
| 2016 | -217.33% | -6765.59% |
| 2015 | 3.26% | -104.47% |
| 2014 | -72.91% | -213.18% |
Cipher Pharmaceuticals Inc. (CPHRF) Average ROE
How has CPHRF ROE performed in the past?
The current ROE of Cipher Pharmaceuticals Inc. (CPHRF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
28.94%
5-year avg
22.47%
10-year avg
-15.32%
Cipher Pharmaceuticals Inc. (CPHRF) ROE vs. Peers
How is CPHRF’s ROE compared to its peers?
Cipher Pharmaceuticals Inc.’s ROE is less than Bionoid Pharma Inc. (33.29%), less than CENTR Brands Corp. (237.06%), greater than CTT Pharmaceutical Holdings, Inc. (-1060.53%), greater than Alterola Biotech, Inc. (-20.20%), greater than Crescita Therapeutics Inc. (-15.60%), less than Cannara Biotech Inc. (7.78%), greater than Knight Therapeutics Inc. (-4.04%), greater than Lowell Farms Inc. (-258.58%), less than Aion Therapeutic Inc. (264.20%), greater than HLS Therapeutics Inc. (-25.45%), greater than Canntab Therapeutics Limited (0%),
| Company | ROE | Market cap |
|---|---|---|
| 33.29% | $5.90M | |
| 237.06% | $622.99K | |
| -1060.53% | $1.40M | |
| -20.20% | $4.38M | |
| -15.60% | $8.58M | |
| 7.78% | $46.44M | |
| -4.04% | $362.06M | |
| -258.58% | $290.39K | |
| 264.20% | $1.84M | |
| -25.45% | $79.80M | |
| 0% | $147.02K |
Build a custom stock screener for Cipher Pharmaceuticals Inc. (CPHRF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cipher Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Cipher Pharmaceuticals Inc. (CPHRF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Cipher Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Cipher Pharmaceuticals Inc.'s ROE?
How is the ROE calculated for Cipher Pharmaceuticals Inc. (CPHRF)?
What is the highest ROE for Cipher Pharmaceuticals Inc. (CPHRF)?
What is the 3-year average ROE for Cipher Pharmaceuticals Inc. (CPHRF)?
What is the 5-year average ROE for Cipher Pharmaceuticals Inc. (CPHRF)?
How does the current ROE for Cipher Pharmaceuticals Inc. (CPHRF) compare to its historical average?